The Leadership Team at InterVenn Biosciences drives the strategic vision and direction of the company, overseeing advancements in glycoproteomic technologies and precision medicine. This team collaborates to align research, intellectual property, and data science initiatives, ensuring innovation and competitive positioning in the oncology and diagnostics spaces while guiding the overall growth and operational success of the company.
View all